# Liquid-liquid phase separation drives immune signaling transduction in cancer: a bibliometric and visualized study from 1992 to 2024

**Authors:** Yanhong Pei, Haijie Liang, Yu Guo, Boyang Wang, Han Wu, Zhijian Jin, Shanyi Lin, Fanwei Zeng, Yifan Wu, Qianyu Shi, Jiuhui Xu, Yi Huang, Tingting Ren, Jiarui Liu, Wei Guo

PMC · DOI: 10.3389/fonc.2025.1509457 · Frontiers in Oncology · 2025-03-04

## TL;DR

This study maps the research on how liquid-liquid phase separation influences immune signaling in cancer from 1992 to 2024.

## Contribution

The first integrative bibliometric analysis of LLPS in immune signaling pathways for cancer.

## Key findings

- Research on LLPS and immune signaling in cancer has rapidly increased since 2020.
- Key signaling pathways like TCR, BCR, and cGAS-STING are linked to LLPS processes.
- China and the USA are leading contributors to this research field.

## Abstract

Liquid–liquid phase separation (LLPS) is a novel concept that could explain how living cells precisely modulate internal spatial and temporal functions. However, a comprehensive bibliometric analysis on LLPS and immune signaling processes in cancer is still scarce. This study aims to perform a bibliometric assessment of research to explore the landscape of LLPS research in immune signaling pathways for cancer.

Utilizing the Web of Science Core Collection database and multiple analysis software, we performed quantitative and qualitative analyses of the study situation between LLPS and immune signaling in cancer from 1992 to 2024.

The corresponding authors were primarily from China and the USA. The most relevant references were the “International Journal of Molecular Sciences”, “Proteomics”. The annual number of publications exhibited a fast upward tendency from 2020 to 2024. The most frequent key terms included expression, separation, activation, immunotherapy, and mechanisms. Qualitative evaluation emphasized the TCR, BCR, cGAS-STING, RIG-1, NF-κB signaling pathways associated with LLPS processes.

This research is the first to integratively map out the knowledge structure and forward direction in the area of immune transduction linked with LLPS over the past 30 years. In summary, although this research area is still in its infancy, illustrating the coordinated structures and communications between cancer and immune signaling with LLPS within a spatial framework will offer deeper insights into the molecular mechanisms of cancer development and further enhance the effectiveness of existing immunotherapies.

## Linked entities

- **Proteins:** Tcr (Third chromosome alpha methyl dopa-resistant), BCR (BCR activator of RhoGEF and GTPase), CGAS (cyclic GMP-AMP synthase), STING1 (stimulator of interferon response cGAMP interactor 1), PLAAT4 (phospholipase A and acyltransferase 4), NFKB1 (nuclear factor kappa B subunit 1)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, BCR (BCR activator of RhoGEF and GTPase) [NCBI Gene 613] {aka ALL, BCR1, CML, D22S11, D22S662, PHL}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, ROBO3 (roundabout guidance receptor 3) [NCBI Gene 64221] {aka HGPPS, HGPPS1, HGPS, RBIG1, RIG1}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}
- **Diseases:** cancer (MESH:D009369)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11913689/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11913689/full.md

## References

111 references — full list in the complete paper: https://tomesphere.com/paper/PMC11913689/full.md

---
Source: https://tomesphere.com/paper/PMC11913689